Clinuvel Pharmaceuticals Ltd (CLVLF) stock
CLVLFOTCAmerican Depositary ReceiptsFiscal year ends June 30Also trades as CUVL
$5.05−0.33 (-6.13%)
Close on Oct 19, 2026Market cap $254.66MP/E 11.0Yield –
Clinuvel Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Clinuvel Pharmaceuticals's enterprise value was $81.91M on Nov 3, 2026, against $218.57M a year earlier. Over the last 2 years it ranged from $81.66M to $486.34M, with a median of $238.42M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $81.91M | -70.7% |
| 2025 | Dec 31, 2025 | $279.52M | -28.9% |
| 2024 | Dec 31, 2024 | $392.91M | – |
See a number that looks wrong?